Semaglutide Reduces Severity of Common Liver Disease in People with HIV

March 5, 2024 -- A weekly injection of semaglutide was safe and reduced the amount of fat in the liver by 31% in people with HIV and metabolic dysfunction-associated steatotic liver disease (MASLD), according to a presentation today at the 2024...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials